Also trades as: WGSWW (NASDAQ) · $vol 0M

$73.09

+2.13 (+3.00%)

Weekly Expected Move ±10.7%

$57 $65 $73 $81 $89

NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 37 · $2.2B mcap · 28M float · 3.05% daily turnover · Short 61% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

51.2 / 100

NoneWeakNarrowWide

Primary source: Intangible Assets · ROIC: -17.2% · 5Y Avg: -80.8%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. WGS shows a Weak competitive edge (51.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -17.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$83

Low

$86

Avg Target

$90

High

Based on 2 analysts since Aug 3, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 10Hold: 1Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$86.50

Analysts2

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-01	Guggenheim	—	$74	$83	+9	+12.3%	$73.92
2026-08-04	Canaccord Genuity	Kyle Mikson	$75	$90	+15	+32.6%	$67.86
2026-06-29	Guggenheim	—	$70	$74	+4	+6.0%	$69.82
2026-06-23	Piper Sandler	David Westenberg	$130	$63	-67	+13.7%	$55.42
2026-05-05	Craig-Hallum	Bill Bonello	$70	$85	+15	+138.8%	$35.59
2026-05-05	BTIG	—	$170	$90	-80	+32.5%	$67.93
2026-05-05	Guggenheim	—	$170	$70	-100	+3.0%	$67.93
2026-05-05	Canaccord Genuity	Kyle Mikson	$100	$75	-25	+10.4%	$67.93
2026-05-05	Wells Fargo	Brandon Couillard	$155	$75	-80	+10.4%	$67.93
2026-04-20	Canaccord Genuity	—	$170	$100	-70	+47.7%	$67.72
2026-02-24	BTIG	Mark Massaro	$200	$170	-30	+95.2%	$87.08
2026-02-24	Piper Sandler	David Westenberg	$120	$130	+10	+49.3%	$87.08
2026-02-23	Jefferies	—	$21	$150	+129	+72.3%	$87.08
2025-12-22	Canaccord Genuity	—	$160	$170	+10	+21.0%	$140.44
2025-12-15	Wells Fargo	—	$34	$155	+121	+2.4%	$151.37
2025-12-12	BTIG	—	$165	$200	+35	+28.7%	$155.36
2025-10-29	BTIG	—	$45	$165	+120	+20.1%	$137.40
2025-10-29	Canaccord Genuity	—	$155	$160	+5	+16.4%	$137.47
2025-10-29	Guggenheim	—	Initiated	$170	—	+23.7%	$137.47
2025-10-20	Canaccord Genuity	—	Initiated	$155	—	+28.2%	$120.94
2025-08-04	Piper Sandler	—	Initiated	$120	—	+10.8%	$108.35
2024-10-24	Craig-Hallum	Bill Bonello	$43	$70	+27	+20.7%	$58.00
2024-08-27	Wells Fargo	Brandon Couillard	Initiated	$34	—	-3.8%	$35.35
2024-07-31	BTIG	Mark Massaro	$35	$45	+10	+49.4%	$30.13
2024-07-10	Craig-Hallum	Bill Bonello	Initiated	$43	—	+44.2%	$29.81
2024-06-26	BTIG	Mark Massaro	$19	$35	+16	+33.6%	$26.19
2024-06-03	Jefferies	Tycho Peterson	Initiated	$21	—	+7.1%	$19.61
2024-04-30	BTIG	Mark Massaro	Initiated	$19	—	+72.7%	$11.00

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. WGS receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-02-26	C-	D+
2026-02-23	C	C-
2026-01-03	C+	C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 21 Grade D

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. WGS scores highest in Growth (52/100) and lowest in Balance Sheet (13/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

1.59

Distress Zone

Piotroski F-Score

4/9

✗ ✗ ✗ ✓ ✗ ✓ ✓ ✗ ✓

Beneish M-Score

-2.59

Unlikely Manipulator

Ohlson O-Score

-5.55

Bankruptcy prob: 0.4%

Low Risk

Credit Rating

Score: 40.4/100

Trend: Deteriorating

Earnings Quality

—

OCF/NI: 0.46x

Accruals: -12.2%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. WGS scores 1.59, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. WGS scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. WGS's score of -2.59 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. WGS's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. WGS receives an estimated rating of BB (score: 40.4/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-20.08x

PEG

-0.01x

P/S

4.80x

P/B

8.89x

P/FCF

-26.91x

P/OCF

—

EV/EBITDA

-27.14x

EV/Revenue

4.57x

EV/EBIT

-20.08x

EV/FCF

-27.37x

Earnings Yield

-5.21%

FCF Yield

-3.72%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. WGS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.001

NI / EBT

Interest Burden

1.029

EBT / EBIT

EBIT Margin

-0.227

EBIT / Rev

Asset Turnover

0.961

Rev / Assets

Equity Multiplier

1.813

Assets / Equity

ROE

-40.8%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. WGS's ROE of -40.8% is driven by Asset Turnover (0.961), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1484 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$73.09

Median 1Y

$32.60

5th Pctile

$5.01

95th Pctile

$211.13

Ann. Volatility

105.6%

Analyst Target

$86.50

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Katherine Stueland Chief Executive Officer	$715,869	$11,738,600	$13,547,219
Kevin Feeley Financial ancial Officer	$500,600	$3,756,926	$4,688,926
Bryan Dechairo Operating rating Officer	$436,154	$2,699,971	$3,582,375

CEO Pay Ratio

74:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $13,547,219

Avg Employee Cost (SGA/emp): $184,018

Employees: 1,300

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

1,300

+30.0% YoY

Revenue / Employee

$328,876

Rev: $427,539,000

Profit / Employee

$-16,170

NI: $-21,021,000

SGA / Employee

$184,018

Avg labor cost proxy

R&D / Employee

$55,405

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	-84.6%	-1.3%	-1.8%	-83.7%	-58.9%	-1.7%	-1.6%	-1.1%	-1.1%	-73.0%	-50.4%	-47.9%	-36.4%	-22.1%	-16.6%	0.6%	0.8%	-7.6%	-30.4%	-40.8%	-40.80%
ROA	-54.8%	-61.0%	-35.5%	-30.7%	-39.2%	-99.9%	-1.0%	-70.1%	-73.6%	-36.5%	-28.7%	-27.1%	-20.2%	-12.5%	-9.2%	0.3%	0.5%	-4.2%	-16.3%	-22.5%	-22.50%
ROIC	6.1%	-17.3%	-3.0%	-83.6%	-80.9%	-2.7%	-2.7%	-1.9%	-1.8%	-65.6%	-48.6%	-35.9%	-22.3%	-8.3%	-5.2%	1.9%	3.3%	-3.4%	-10.7%	-17.2%	-17.16%
ROCE	-61.7%	-53.6%	-30.7%	-29.7%	-51.1%	-1.5%	-1.4%	-1.3%	-1.3%	-48.1%	-38.3%	-33.8%	-24.6%	-12.9%	-8.7%	1.8%	1.9%	-4.0%	-17.9%	-25.4%	-25.39%
Gross Margin	-19.2%	15.9%	10.4%	-81.8%	16.3%	-26.6%	35.3%	38.5%	47.4%	53.6%	59.9%	60.9%	62.2%	69.2%	67.1%	69.0%	72.4%	65.2%	66.7%	68.4%	68.37%
Operating Margin	-2.0%	-2.0%	-1.7%	-4.5%	-1.1%	-5.3%	-1.4%	-1.1%	-80.6%	-44.7%	-21.9%	-15.0%	-10.1%	9.2%	-5.2%	8.7%	-2.8%	-11.3%	-25.6%	-15.3%	-15.25%
Net Margin	75.8%	-69.9%	-1.4%	-2.4%	-93.2%	-5.0%	-1.4%	-95.9%	-79.3%	-44.9%	-32.4%	-41.4%	-10.8%	5.7%	-7.5%	10.5%	-6.5%	-14.6%	-61.9%	-15.5%	-15.50%
EBITDA Margin	90.1%	-58.7%	-1.3%	-3.5%	-96.5%	-4.5%	-1.2%	-84.8%	-48.8%	-34.0%	-23.2%	-33.0%	-2.4%	15.0%	0.3%	17.1%	-0.3%	-9.0%	-53.7%	-9.1%	-9.05%
FCF Margin	-83.1%	-98.3%	-1.2%	-1.6%	-1.4%	-1.4%	-1.4%	-1.2%	-1.1%	-91.6%	-66.0%	-39.4%	-22.4%	-11.1%	-4.0%	0.2%	3.8%	3.3%	-6.5%	-16.7%	-16.68%
OCF Margin	-71.8%	-89.7%	-1.1%	-1.5%	-1.3%	-1.4%	-1.3%	-1.1%	-1.0%	-88.8%	-63.4%	-37.7%	-20.6%	-9.3%	-0.6%	3.6%	8.3%	7.8%	-2.1%	-10.7%	-10.72%
ROE 3Y Avg	snapshot only																				-34.53%
ROE 5Y Avg	snapshot only																				-59.43%
ROA 3Y Avg	snapshot only																				-17.33%
ROIC 3Y Avg	snapshot only																				-35.76%
ROIC Economic	snapshot only																				-11.89%
Cash ROA	snapshot only																				-10.12%
Cash ROIC	snapshot only																				-17.45%
CROIC	snapshot only																				-27.16%
NOPAT Margin	snapshot only																				-10.54%
Pretax Margin	snapshot only																				-23.39%
R&D / Revenue	snapshot only																				18.34%
SGA / Revenue	snapshot only																				64.48%
SBC / Revenue	snapshot only																				7.86%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	-4.82	-4.38	-5.74	-2.50	-1.19	-0.19	-0.45	-0.31	-0.20	-0.41	-1.76	-5.92	-13.77	-39.68	-64.63	1953.47	1489.52	-166.38	-24.21	-19.18	-20.080
P/S Ratio	7.31	5.08	3.72	2.23	1.45	0.44	1.08	0.64	0.45	0.35	1.07	2.86	4.30	6.79	7.55	7.58	7.71	8.18	4.26	4.49	4.797
P/B Ratio	4.08	2.78	2.28	0.67	0.60	0.40	0.74	0.51	0.37	0.31	1.15	3.59	5.62	8.46	9.69	9.91	10.62	11.35	7.41	8.35	8.892
P/FCF	-8.80	-5.16	-3.04	-1.40	-1.03	-0.31	-0.79	-0.56	-0.43	-0.38	-1.62	-7.25	-19.17	-61.04	-190.63	3309.14	200.61	245.23	-65.75	-26.91	-26.908
P/OCF	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	210.89	93.49	105.10	—	—	—
EV/EBITDA	-3.72	-3.21	-4.84	-1.15	-0.71	-0.08	-0.19	-0.16	-0.14	-0.44	-2.45	-8.48	-19.44	-81.29	-233.17	89.92	96.19	524.92	-38.79	-27.14	-27.141
EV/Revenue	5.25	3.34	2.52	1.15	0.96	0.18	0.46	0.30	0.26	0.30	1.12	2.90	4.30	6.71	7.42	7.52	7.61	8.14	4.25	4.57	4.565
EV/EBIT	-3.49	-2.92	-3.98	-1.01	-0.65	-0.07	-0.17	-0.14	-0.12	-0.35	-1.89	-6.50	-14.09	-43.46	-74.46	391.50	386.56	-187.02	-25.13	-20.08	-20.080
EV/FCF	-6.32	-3.40	-2.06	-0.72	-0.68	-0.13	-0.34	-0.26	-0.24	-0.33	-1.70	-7.35	-19.16	-60.31	-187.24	3284.83	197.90	243.87	-65.66	-27.37	-27.368
Earnings Yield	-20.7%	-22.8%	-17.4%	-40.0%	-84.0%	-5.4%	-2.2%	-3.3%	-4.9%	-2.5%	-56.7%	-16.9%	-7.3%	-2.5%	-1.5%	0.1%	0.1%	-0.6%	-4.1%	-5.2%	-5.21%
FCF Yield	-11.4%	-19.4%	-32.9%	-71.7%	-96.6%	-3.3%	-1.3%	-1.8%	-2.4%	-2.6%	-61.5%	-13.8%	-5.2%	-1.6%	-0.5%	0.0%	0.5%	0.4%	-1.5%	-3.7%	-3.72%
Price/Tangible Book	snapshot only																				20.148
EV/Gross Profit	snapshot only																				6.694
Shareholder Yield	snapshot only																				0.00%

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	7.55	4.77	4.08	1.97	1.89	1.47	2.29	2.53	2.51	3.10	3.22	2.38	2.41	3.61	3.25	2.87	2.71	2.46	3.09	3.30	3.301
Quick Ratio	7.11	4.44	3.72	1.76	1.62	1.38	2.18	2.39	2.38	2.95	2.99	2.22	2.27	3.42	3.07	2.70	2.59	2.34	2.95	3.06	3.062
Debt/Equity	0.03	0.08	0.22	0.12	0.14	0.30	0.23	0.25	0.29	0.53	0.59	0.60	0.57	0.47	0.45	0.41	0.39	0.49	0.66	0.69	0.685
Net Debt/Equity	-1.15	-0.95	-0.73	-0.32	-0.20	-0.24	-0.42	-0.27	-0.16	-0.05	0.05	0.05	-0.00	-0.10	-0.17	-0.07	-0.14	-0.06	-0.01	0.14	0.143
Debt/Assets	0.02	0.06	0.14	0.08	0.09	0.14	0.14	0.16	0.18	0.29	0.31	0.30	0.28	0.28	0.26	0.25	0.23	0.27	0.33	0.35	0.348
Debt/EBITDA	-0.04	-0.15	-0.70	-0.41	-0.25	-0.14	-0.14	-0.17	-0.19	-0.86	-1.22	-1.40	-1.96	-4.61	-10.93	3.77	3.56	22.93	-3.47	-2.19	-2.190
Net Debt/EBITDA	1.46	1.66	2.30	1.08	0.37	0.11	0.26	0.18	0.10	0.07	-0.10	-0.12	0.01	0.99	4.22	-0.67	-1.32	-2.92	0.05	-0.46	-0.456
Interest Coverage	-118.20	-85.64	-43.78	-72.43	-109.50	-189.84	-187.56	-170.36	-207.32	-72.99	-59.82	-43.95	-24.64	-15.56	-10.69	2.32	2.91	-7.32	-28.62	-34.62	-34.622
Equity Multiplier	1.54	1.43	1.57	1.46	1.48	2.15	1.66	1.61	1.64	1.84	1.90	2.01	2.00	1.71	1.73	1.67	1.69	1.85	1.99	1.97	1.972
Cash Ratio	snapshot only																				1.776
Debt Service Coverage	snapshot only																				-25.614
Cash to Debt	snapshot only																				0.792
FCF to Debt	snapshot only																				-0.453
Defensive Interval	snapshot only																				212.9 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.36	0.53	0.55	0.34	0.32	0.43	0.42	0.34	0.33	0.42	0.47	0.56	0.65	0.73	0.79	0.85	0.89	0.86	0.93	0.96	0.961
Inventory Turnover	7.43	7.42	5.67	6.06	6.17	11.10	9.91	7.72	6.11	10.03	9.16	9.82	10.76	11.43	9.45	10.69	11.44	10.95	11.25	9.72	9.715
Receivables Turnover	10.27	7.25	5.65	5.40	7.23	6.79	6.35	6.02	5.54	5.40	7.27	8.37	7.62	8.75	8.91	9.86	8.11	7.65	7.20	6.90	6.904
Payables Turnover	5.38	6.07	3.56	4.53	5.71	5.76	4.56	5.40	6.10	4.00	4.73	6.47	8.88	12.21	9.05	20.40	20.95	25.87	10.37	33.34	33.343
DSO	36	50	65	68	50	54	58	61	66	68	50	44	48	42	41	37	45	48	51	53	52.9 days
DIO	49	49	64	60	59	33	37	47	60	36	40	37	34	32	39	34	32	33	32	38	37.6 days
DPO	68	60	103	81	64	63	80	68	60	91	77	56	41	30	40	18	17	14	35	11	10.9 days
Cash Conversion Cycle	17	39	26	47	46	23	14	40	66	13	13	24	41	44	39	53	59	67	48	79	79.5 days
Fixed Asset Turnover	snapshot only																				5.173
Operating Cycle	snapshot only																				90.4 days
Cash Velocity	snapshot only																				3.428
Capital Intensity	snapshot only																				1.060

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	—	2.3%	57.6%	9.1%	5.9%	10.6%	10.9%	23.7%	-10.7%	-13.7%	-0.9%	3.1%	29.4%	50.8%	48.8%	48.7%	50.5%	40.0%	34.1%	25.4%	25.42%
Net Income	—	-95.4%	58.8%	53.2%	15.2%	-1.2%	-3.1%	-1.9%	-63.5%	68.0%	74.7%	76.2%	81.8%	70.3%	71.4%	1.0%	1.0%	59.8%	-1.0%	-76.6%	-76.65%
EPS	—	-50.3%	68.7%	74.2%	53.1%	-38.9%	-50.5%	-16.8%	26.9%	85.5%	80.5%	77.3%	82.7%	71.4%	73.5%	1.0%	1.0%	59.6%	-93.5%	-76.8%	-76.76%
FCF	—	-6.0%	-2.2%	-1.9%	-78.1%	-59.9%	-23.2%	10.7%	31.6%	44.3%	51.8%	64.7%	72.8%	81.7%	91.1%	1.0%	1.3%	1.4%	-1.2%	-92.3%	-92.32%
EBITDA	—	-82.0%	65.8%	45.2%	-0.3%	-1.5%	-4.1%	-1.4%	-27.1%	74.6%	80.9%	81.4%	85.0%	81.9%	89.6%	1.4%	1.5%	1.3%	-3.6%	-3.5%	-3.52%
Op. Income	—	-2.6%	-5.4%	-24.3%	-0.7%	-49.6%	-88.4%	-15.7%	-4.6%	73.0%	79.0%	82.4%	88.0%	87.1%	89.5%	1.1%	1.2%	45.9%	-1.4%	-12.2%	-12.15%
OCF Growth	snapshot only																				-4.74%
Asset Growth	snapshot only																				3.80%
Equity Growth	snapshot only																				-11.88%
Debt Growth	snapshot only																				46.35%
Shares Change	snapshot only																				-0.15%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	—	—	—	—	—	—	—	—	—	46.9%	20.1%	11.6%	7.0%	12.9%	17.8%	23.8%	20.3%	22.1%	25.5%	24.3%	24.33%
Revenue 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	46.2%	28.1%	21.0%	21.00%
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Profit 3Y	—	—	—	—	—	—	—	—	—	5.0%	—	—	—	—	2.4%	—	—	—	—	1.1%	1.15%
Gross Profit 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.7%	—	—	—
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets 3Y	—	—	—	—	—	—	—	—	—	18.5%	21.6%	30.4%	-12.2%	-8.9%	-4.8%	-20.8%	-15.9%	1.5%	-2.4%	0.4%	0.36%
Assets 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	17.8%	18.2%	22.4%	22.36%
Equity 3Y	—	—	—	—	—	—	—	—	—	2.7%	—	—	-19.4%	-14.2%	-7.9%	-24.2%	-19.6%	6.7%	-8.2%	-6.2%	-6.22%
Book Value 3Y	—	—	—	—	—	—	—	—	—	1.2%	—	—	-50.3%	-44.5%	-41.0%	-46.9%	-40.7%	-19.0%	-19.1%	-11.0%	-10.97%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	—	—	—	—	—	0.85	0.91	0.93	0.23	0.53	0.76	0.93	0.36	0.47	0.73	0.85	0.72	0.91	0.89	0.87	0.866
Earnings Stability	—	—	—	—	—	0.94	0.29	0.16	0.48	0.10	0.01	0.09	0.22	0.03	0.20	0.39	0.53	0.17	0.29	0.40	0.399
Margin Stability	—	—	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.00	0.00	0.18	0.183
Rev. Growth Consistency	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	0.00	0.00	0.00	1.00	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.00	0.00	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.000
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earnings Persistence	—	—	—	—	—	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.20	0.20	0.50	0.50	0.20	0.200
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	—	—	—	—	—	12.47	—	—	-1.13	0.63	0.36	0.36	0.74	1.25	0.99	1.14	1.11	0.42	0.09	-0.14	-0.135
Gross Margin Trend	—	—	—	—	—	-0.11	-0.07	0.21	0.24	0.51	0.53	0.55	0.49	0.47	0.44	0.33	0.30	0.14	0.10	0.07	0.066
FCF Margin Trend	—	—	—	—	—	-0.70	-0.45	-0.05	0.04	0.29	0.63	0.98	1.01	1.06	0.97	0.78	0.69	0.55	0.29	0.03	0.029
Sustainable Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.6%	0.8%	—	—	—	—
Internal Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.3%	0.5%	—	—	—	—

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	0.47	0.78	1.76	1.70	1.09	0.58	0.55	0.53	0.47	1.02	1.04	0.78	0.66	0.55	0.05	9.26	15.93	-1.58	0.12	0.46	0.458
FCF/OCF	1.16	1.10	1.07	1.05	1.05	1.04	1.04	1.04	1.03	1.03	1.04	1.05	1.09	1.19	6.88	0.06	0.47	0.43	3.08	1.56	1.556
FCF/Net Income	snapshot only																				0.713
CapEx/Revenue	11.3%	8.6%	8.5%	8.3%	7.2%	6.1%	4.9%	4.4%	3.0%	2.8%	2.6%	1.8%	1.8%	1.8%	3.4%	3.4%	4.4%	4.4%	4.4%	6.0%	5.96%
CapEx/Depreciation	snapshot only																				1.008
Accruals Ratio	-0.29	-0.14	0.27	0.21	0.04	-0.42	-0.45	-0.33	-0.39	0.01	0.01	-0.06	-0.07	-0.06	-0.09	-0.03	-0.07	-0.11	-0.14	-0.12	-0.122
Sloan Accruals	snapshot only																				0.024
Cash Flow Adequacy	snapshot only																				-1.798

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0%	0.0%	—	—	—	—
FCF Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0%	0.0%	0.0%	—	—	—
Total Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0%	0.0%	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-49.7%	-73.6%	-1.1%	-2.3%	-59.1%	0.0%	-56.0%	-36.1%	-58.2%	-2.0%	-3.2%	-0.0%	-1.3%	-2.2%	-2.5%	-2.3%	-1.9%	0.0%	-4.4%	-0.7%	-0.66%
Total Shareholder Return	-49.7%	-73.6%	-1.1%	-2.3%	-59.1%	0.0%	-56.0%	-36.1%	-58.2%	-2.0%	-3.2%	-0.0%	-1.3%	-2.2%	-2.5%	-2.3%	-1.9%	0.0%	-4.4%	-0.7%	-0.66%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	1.00	1.00	1.00	0.78	0.85	0.92	0.92	1.00	1.00	0.99	0.99	0.99	0.99	0.99	1.00	0.92	0.83	0.99	1.00	1.00	1.001
Interest Burden (EBT/EBIT)	1.01	1.01	1.02	1.01	0.97	0.98	0.98	0.97	1.01	1.02	1.03	1.09	1.03	1.12	1.17	0.22	0.32	1.14	1.03	1.03	1.029
EBIT Margin	-1.50	-1.14	-0.63	-1.13	-1.47	-2.59	-2.65	-2.16	-2.20	-0.85	-0.59	-0.45	-0.31	-0.15	-0.10	0.02	0.02	-0.04	-0.17	-0.23	-0.227
Asset Turnover	0.36	0.53	0.55	0.34	0.32	0.43	0.42	0.34	0.33	0.42	0.47	0.56	0.65	0.73	0.79	0.85	0.89	0.86	0.93	0.96	0.961
Equity Multiplier	1.54	2.05	5.16	2.73	1.50	1.71	1.62	1.51	1.53	2.00	1.75	1.77	1.80	1.77	1.81	1.81	1.82	1.79	1.86	1.81	1.813

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$-51.91	$-33.57	$-17.66	$-16.64	$-24.32	$-46.63	$-26.57	$-19.44	$-17.79	$-6.77	$-5.18	$-4.41	$-3.08	$-1.94	$-1.37	$0.05	$0.07	$-0.78	$-2.65	$-3.58	$-3.58
Book Value/Share	$61.39	$53.03	$44.49	$62.26	$48.65	$21.55	$16.37	$11.65	$9.86	$8.78	$7.95	$7.29	$7.55	$9.09	$9.14	$9.31	$10.15	$11.46	$8.66	$8.22	$8.22
Tangible Book/Share	$61.39	$53.03	$44.49	$25.64	$16.44	$5.70	$7.24	$4.58	$3.03	$2.13	$1.46	$1.07	$1.56	$3.21	$3.63	$2.94	$3.71	$4.69	$3.67	$3.41	$3.41
Revenue/Share	$34.26	$29.00	$27.27	$18.67	$20.03	$19.93	$11.16	$9.30	$8.01	$7.80	$8.51	$9.15	$9.86	$11.32	$11.73	$12.18	$13.97	$15.90	$15.09	$15.30	$15.30
FCF/Share	$-28.46	$-28.50	$-33.33	$-29.79	$-28.00	$-28.33	$-15.16	$-10.72	$-8.56	$-7.14	$-5.62	$-3.61	$-2.21	$-1.26	$-0.46	$0.03	$0.54	$0.53	$-0.98	$-2.55	$-2.55
OCF/Share	$-24.60	$-26.02	$-31.02	$-28.24	$-26.56	$-27.11	$-14.62	$-10.31	$-8.33	$-6.92	$-5.40	$-3.45	$-2.04	$-1.06	$-0.07	$0.44	$1.15	$1.24	$-0.32	$-1.64	$-1.64
Cash/Share	$72.37	$54.74	$42.54	$27.81	$16.58	$11.67	$10.67	$6.16	$4.43	$5.01	$4.33	$4.01	$4.30	$5.23	$5.65	$4.52	$5.39	$6.37	$5.82	$4.46	$4.46
EBITDA/Share	$-48.40	$-30.20	$-14.20	$-18.60	$-26.83	$-46.67	$-26.50	$-17.62	$-15.26	$-5.36	$-3.89	$-3.13	$-2.18	$-0.93	$-0.37	$1.02	$1.10	$0.25	$-1.65	$-2.57	$-2.57
Debt/Share	$1.73	$4.49	$9.93	$7.68	$6.76	$6.55	$3.75	$2.96	$2.85	$4.61	$4.73	$4.39	$4.28	$4.30	$4.08	$3.84	$3.93	$5.65	$5.73	$5.63	$5.63
Net Debt/Share	$-70.65	$-50.25	$-32.61	$-20.14	$-9.83	$-5.12	$-6.91	$-3.20	$-1.58	$-0.40	$0.40	$0.38	$-0.01	$-0.93	$-1.57	$-0.68	$-1.46	$-0.72	$-0.08	$1.17	$1.17

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1.592
Altman Z-Prime	snapshot only																				0.076
Piotroski F-Score	2	5	3	3	2	2	4	4	4	3	4	4	4	6	6	8	8	6	2	4	4
Beneish M-Score	—	-3.79	-2.35	0.11	22.78	7.92	3.92	-6.76	-6.06	-3.52	-2.53	-2.96	-2.68	-2.53	-2.46	-1.94	-2.32	-2.09	-2.64	-2.59	-2.593
Ohlson O-Score	snapshot only																				-5.552
ROIC (Greenblatt)	snapshot only																				-39.80%
Net-Net WC	snapshot only																				$0.31
EVA	snapshot only																				$-75788610.00

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BB
Credit Score	49.34	44.62	35.94	28.26	28.38	26.12	30.29	30.81	30.54	29.98	30.08	28.95	28.53	56.16	62.32	71.35	74.38	55.98	40.59	40.42	40.418
Credit Grade	snapshot only																				12
Credit Trend	snapshot only																				-30.928
Implied Spread (bps)	snapshot only																				475.000
Industry Credit Rank	snapshot only																				36
Sector Credit Rank	snapshot only																				32

WGS NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet